MktsMarkets

Century Therapeutics, Inc.
NASDAQ: IPSCKey statistics
IPSC News
Stories mentioning IPSC from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | 109,164 | 4,172 | 791.00 | 771.00 | ||||
| Cost of Goods Sold | ||||||||
| Gross Profit | 0.00 | 0.00 | 0.00 | |||||
| Operating Expenses | ||||||||
| Research & Development | 12.00 | |||||||
| Sales General & Admin | ||||||||
| Total Operating Expenses | 23,684 | 20,657 | 36,124 | 34,664 | 34,988 | 41,456 | 35,580 | 35,526 |
| Operating Income (Loss) | (23,684) | (20,657) | (36,124) | (34,664) | 74,176 | (37,284) | (34,789) | (34,755) |
| Interest Income | ||||||||
| Interest Expense | ||||||||
| Other Expense | 20.00 | 103.00 | 97.00 | 113.00 | (38.00) | 105.00 | 250.00 | (12.00) |
| Pretax Income | (19,245) | (34,422) | (32,541) | 76,560 | (34,296) | (31,234) | (31,185) | |
| Tax Provision | 1,775 | (8.00) | 22.00 | |||||
| Net Income (Loss) | (21,645) | (19,177) | (34,422) | (32,541) | 76,560 | (36,071) | (31,226) | (31,207) |
| Earnings Per Share (Basic) | (0.11) | (0.22) | (0.40) | (0.38) | 0.89 | (0.46) | (0.37) | (0.38) |
| Earnings Per Share (Diluted) | (0.11) | (0.22) | (0.40) | (0.38) | 0.89 | (0.46) | (0.37) | (0.38) |
| Weighted Average Shares Outstanding (Basic) | 193,475 | 86,557 | 86,464 | 86,238 | 86,021 | 78,649 | 84,704 | 82,092 |
| Weighted Average Shares Outstanding (Diluted) | 193,475 | 86,557 | 86,464 | 86,238 | 86,099 | 78,649 | 84,704 | 82,092 |
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About IPSC
Century Therapeutics, Inc. (NASDAQ: IPSC) is a stock listed on the Nasdaq Stock Market under the ticker symbol IPSC. It last traded at $1.68 (Nov 6, 2026, 9:30 AM ET), up 11.3% on the day. That gives Century Therapeutics a market capitalisation of $304.2M.
Over the past 52 weeks IPSC has traded between $0.4300 and $3.04.
For the quarter ended Mar 31, 2026 it reported a net loss of $21.6M.
| Quarter ended | Revenue | Net income |
|---|---|---|
| Mar 31, 2026 | — | -$21.6M |
| Dec 31, 2025 | — | -$19.2M |
| Sep 30, 2025 | — | -$34.4M |
| Jun 30, 2025 | — | -$32.5M |
From Century Therapeutics’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…